Sartorius Stedim Biotech SA (DIM), with a market capitalization of $135.93 million, reported robust earnings for the first quarter of 2025, exceeding analyst expectations with an earnings per share ...

Sartorius Stedim Biotech SA Sartorius Stedim Biotech SA: Information on Document Availability 17-Feb-2025 / 10:56 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group.

In a challenging environment, Sartorius Stedim Biotech, a leading provider of innovative technologies for the manufacture of biologics, closed the fiscal year with a solid performance. With sales ...

Jan 28 (Reuters) - Shares in Sartorius (SATG.DE), opens new tab jumped 15.6% on Tuesday after the Franco-German lab supplies maker's preliminary annual results beat expectations and despite a ...

Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts. This state-of-the-art facility is designed ...

Sartorius Stedim Biotech opened its new centre for Bioprocess Innovation in Marlborough French biopharmaceutical company Sartorius Stedim Biotech has announced the opening of its new centre for ...

In 2025, Sartorius Stedim Biotech will add two multi-modality GMP suites, operating on Sartorius workflows and equipment. The suites will allow customers to extend their process development ...

Sartorius Stedim Biotech, the bioprocess subsidiary ... as it is the only vendor to have developed a 2,500-liter single-use system, albeit for a single customer as part of a custom process.

Sartorius Stedim Biotech, a leading partner of the biopharma industry, has released its Universal Registration Document 2023 including the Annual Financial Report today. The document is available ...

Sartorius Stedim Biotech SA / Key word(s): Dividend/AGM/EGM Board of Directors of Sartorius Stedim Biotech resolves to propose a dividend of 0.69 euros per share to the Annual Shareholders ...

Ladies and gentlemen, welcome to the Sartorius and Sartorius Stedim Biotech conference call and live webcast on the preliminary full year 2023 results. I'm Sascha, the Chorus Call operator.